Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges without Dedicated Psychedelic Research Groups
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & Manufacturing

Medical University Innsbruck

Austria
4 Trials

Leading Austrian medical university in Innsbruck. Researchers here have investigated the structural biology of psilocybin-biosynthesizing enzymes with the aim of optimizing sustainable psilocybin production, while also contributing to clinical research as European psychedelic frameworks evolve.

Academic Research

0 papers

Published Papers

0

Trial Involvement

4

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
Austria
Website
Visit

Sponsored Trials

2
CompletedNA

Esketamine Treatment for Depressive Episodes With Suicidal Ideation in Mood Disorders

Start Date
Compounds
Esketamine, Placebo
WithdrawnIII

ECT vs. Esketamine

Start Date
Compounds
Esketamine

Collaborated Trials

2
CompletedNA

Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression

Start Date
Compounds
Esketamine, Placebo
CompletedNA

Low-dose S-ketamine in Women With Prenatal Depression

Start Date
Compounds
Ketamine, Placebo